Brii Biosciences' market value is the price at which a share of Brii Biosciences trades on a public exchange. It measures the collective expectations of Brii Biosciences Limited investors about its performance. Brii Biosciences is trading at 0.19 as of the 24th of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.19. With this module, you can estimate the performance of a buy and hold strategy of Brii Biosciences Limited and determine expected loss or profit from investing in Brii Biosciences over a given investment horizon. Check out Brii Biosciences Correlation, Brii Biosciences Volatility and Brii Biosciences Alpha and Beta module to complement your research on Brii Biosciences.
Please note, there is a significant difference between Brii Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Brii Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brii Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Brii Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Brii Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Brii Biosciences.
0.00
10/26/2025
No Change 0.00
0.0
In 3 months and 1 day
01/24/2026
0.00
If you would invest 0.00 in Brii Biosciences on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Brii Biosciences Limited or generate 0.0% return on investment in Brii Biosciences over 90 days. Brii Biosciences is related to or competes with NDT Pharmaceuticals, Molecular Partners, Innate Pharma, NervGen Pharma, JW Therapeutics, Scancell Holdings, and BICO Group. Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous sys... More
Brii Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Brii Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Brii Biosciences Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brii Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Brii Biosciences' standard deviation. In reality, there are many statistical measures that can use Brii Biosciences historical prices to predict the future Brii Biosciences' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brii Biosciences. Your research has to be compared to or analyzed against Brii Biosciences' peers to derive any actionable benefits. When done correctly, Brii Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Brii Biosciences.
Brii Biosciences January 24, 2026 Technical Indicators
Brii Biosciences secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Brii Biosciences Limited exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Brii Biosciences' Standard Deviation of 2.6, risk adjusted performance of (0.08), and Mean Deviation of 0.6409 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Brii Biosciences are expected to decrease at a much lower rate. During the bear market, Brii Biosciences is likely to outperform the market. At this point, Brii Biosciences has a negative expected return of -0.33%. Please make sure to confirm Brii Biosciences' information ratio, as well as the relationship between the skewness and day median price , to decide if Brii Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
Brii Biosciences Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Brii Biosciences time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Brii Biosciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current Brii Biosciences price fluctuation can be explain by its past prices.
Brii Biosciences financial ratios help investors to determine whether Brii Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brii with respect to the benefits of owning Brii Biosciences security.